AI assistant
ALBEMARLE CORP — Director's Dealing 2021
Aug 10, 2021
30590_dirs_2021-08-10_cc20db26-fb4f-44e2-a3c2-d8712f90da24.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ALBEMARLE CORP (ALB)
CIK: 0000915913
Period of Report: 2021-08-10
Reporting Person: Crawford Raphael Goszcz (President, Catalysts)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-08-10 | Common Stock | M | 5021 | $118.75 | Acquired | 22340 | Direct |
| 2021-08-10 | Common Stock | S | 3220 | $240.48 | Disposed | 19120 | Direct |
| 2021-08-10 | Common Stock | S | 1801 | $241.16 | Disposed | 17319 | Direct |
| 2021-08-10 | Common Stock | S | 4500 | $240.05 | Disposed | 12819 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-08-10 | Stock Option | $118.75 | M | 5021 | Disposed | 2028-02-23 | Common Stock (5021.0) | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $240.10 to 241.03, inclusive. The reporting person undertakes to provide to Albemarle Corporation, any security holder of Albemarle Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $241.11 to 241.29, inclusive. The reporting person undertakes to provide to Albemarle Corporation, any security holder of Albemarle Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $239.90 to $240.76, inclusive. The reporting person undertakes to provide to Albemarle Corporation, any security holder of Albemarle Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4: On February 23, 2018, the reporting person was granted a 10-year option exercisable for 5,021 shares of Common Stock. The option cliff-vested on 2/23/2021.